Elisa Agostinetto, David Venet, Paulus Krisanto, Delphine Loirat, Philippe Georges Aftimos, Zoe Denis, Hans Wildiers, Nicolaas Van Renne, François Ghiringhelli, Evandro de Azambuja, Anthony Gonçalves, Françoise Rothé, Donatienne Taylor, Michail Ignatiadis, Tom Van den Mooter, Francois P. Duhoux, Jean-Luc Canon, Florian Clatot, Christos Sotiriou, Laurence Buisseret. "First-line durvalumab plus chemotherapy with or without oleclumab for locally advanced or metastatic triple-negative breast cancer: SYNERGY overall survival and circulating tumor DNA analysis.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1097